Thinking of Buying Valeant? Consider These 2 Stocks Instead

These two companies also have a remarkable track record, but aren’t quite as polarizing.

| More on:

There is perhaps no other company in Canada as polarizing as Valeant Pharmaceuticals (TSX: VRX)(NYSE: VRX). As an example, two famous hedge fund investors in the United States, Bill Ackman (who owns a sizable stake) and Jim Chanos (who is betting against the company), disagree on where the stock price is headed. Both of them are very well respected, but at least one of them will be wrong about Valeant.

If you’re thinking of siding with Mr. Ackman, then it’s clear that a strong management track record is more important to you than a company’s transparency. You’re also willing to pay a premium price for a company that’s performing well. So with that in mind, you may want to consider these two names instead.

1. Brookfield Asset Management

Like Valeant, shares of Brookfield Asset Management (TSX: BAM.A)(NYSE: BAM) have done extraordinarily well, returning 19% per year over the past 20 years. Over a time period this long, you can’t claim that luck is involved; such a track record can only come from buying and selling assets smartly.

Also like Valeant, Brookfield is a very difficult company to figure out, with numerous moving parts and changes to its organizational structure. Investors who own the stock are owning it for its track record.

Fortunately, Brookfield is not so expensive. After adjusting for the public companies it owns, it trades at only about 15 times forward earnings.

2. Constellation Software

Anyone who has owned Constellation Software (TSX: CSU) for five years or more has been richly rewarded. The company originally became public back in 2006 at less than $20 per share, and eight years later now trades at nearly $250.

The company’s success comes from CEO Mark Leonard and his management team smartly buying up software companies, typically for under $5 million, and them letting run on their own. Needless to say, it’s worked wonders.

As a bonus, there aren’t the same transparency issues with Constellation that come with Brookfield and Valeant; the company is very straightforward with investors. Unfortunately, Constellation’s shares are very expensive. Last year, the company made $4.39 per share in income and just under $10 per share in free cash flow. These are fairly small numbers for a company with a $247 share price. But if the company can continue to grow as it has in the past, then the shares are undervalued.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Benjamin Sinclair holds no positions in any of the stocks mentioned in this article. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

stock research, analyze data
Dividend Stocks

Is it Too Late to Buy Dollarama Stock?

Dollarama (TSX:DOL) stock is up almost 200% from its 2020 lows. Is it still a buy?

Read more »

data analytics, chart and graph icons with female hands typing on laptop in background
Dividend Stocks

Down by 25%: Is Canadian Tire Stock a Buy in February 2024?

Take a closer look at this Canadian retail stock if you are looking for low-cost additions to your self-directed portfolio…

Read more »

Golden crown on a red velvet background
Dividend Stocks

Cash Kings: The Top 2 Canadian Stocks That Pay Monthly

Two Canadian stocks are cash kings to income investors for their generous dividends and monthly payouts.

Read more »

Dice engraved with the words buy and sell
Bank Stocks

Royal Bank of Canada: Buy, Sell, or Hold After Solid Q1 2024 Earnings?

Royal Bank is up more than 20% from the 12-month low. Are more gains on the way?

Read more »

A close up image of Canadian $20 Dollar bills
Dividend Stocks

2 No-Brainer Stocks to Buy Right Now for Less Than $20

Cheap TSX stocks such as Savaria have the potential to deliver steady gains to long-term shareholders in 2024.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Stocks for Beginners

Can Cargojet Stock Double in 5 Years? Here’s What it Would Take

Cargojet (TSX:CJT) stock has fallen dramatically in the last five years after climbing to all-time highs. So, what can it…

Read more »

sad concerned deep in thought
Investing

Better Buy: Scotiabank or CIBC?

Let's dive into whether Bank of Nova Scotia (TSX:BNS) or Canadian Imperial Bank of Commerce (TSX:CM) is the better bet…

Read more »

Oil pipes in an oil field
Energy Stocks

Here’s Why Enbridge Stock Looks Like a Great Buy

Consider looking at Enbridge (TSX:ENB) if you seek high-yielding but safe dividends for your self-directed portfolio.

Read more »